Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2014; 20(23): 7223-7230
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7223
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7223
Table 1 Comorbidity scoring systems for patients with cirrhosis
| Target population | Charlson comorbidity index | CirCom | CCI-OLT |
| Patients with any disease | Patients with cirrhosis | Orthotopic liver transplant recipients | |
| HIV/AIDS | 6 | ||
| Cancer (metastatic) | 6 | 31 | |
| Cancer (non-metastatic or hematologic) | 2 | 11 | |
| Liver disease (mild) | 1 | ||
| Liver disease (severe) | 3 | ||
| Diabetes (no complications) | 1 | 1 | |
| Diabetes (with complications) | 2 | 1 | |
| Kidney disease | 2 | 3 | 2 |
| Hemiplegia | 2 | ||
| Peptic ulcer | 1 | ||
| Connective tissue disease | 1 | 2 | |
| Chronic obstructive lung disease | 1 | 1 | 3 |
| Dementia | 1 | ||
| Epilepsy | 1 | ||
| Cerebrovascular disease | 1 | ||
| Peripheral vascular disease | 1 | 1 | |
| Congestive heart failure | 1 | 1 | |
| Acute myocardial infarction | 1 | 11 | 2 |
| Substance abuse other than alcoholism | 1 |
Table 2 Effects of comorbid diseases on the mortality of patients with liver cirrhosis in the CirCom cohort of 12976 Danish cirrhosis patients. Hazard ratios are adjusted for gender and age differences[3]
| Comorbidity | Hazard ratio (95%CI) |
| Diabetes with complications | 1.16 (1.10-1.22) |
| Diabetes without complications | 1.03 (0.98-1.08) |
| Acute myocardial infarction | 1.59 (1.40-1.79) |
| Peripheral arterial disease | 1.29 (1.18-1.40) |
| Heart failure | 1.27 (1.20-1.34) |
| Valvular heart disease | 1.17 (1.04-1.30) |
| Cardiomyopathy | 1.16 (1.03-1.30) |
| Arterial hypertension with complications | 1.16 (0.98-1.37) |
| Cardiac arrhythmia | 1.14 (1.08-1.20) |
| Mesenteric vascular disease | 1.13 (0.85-1.49) |
| Ischemic heart disease without myocardial infarction | 1.13 (1.06-1.21) |
| Mesenteric vascular disease | 1.13 (0.85-1.49) |
| Cerebrovascular disease | 1.09 (1.02-1.16) |
| Venous thromboembolism | 1.20 (1.08-1.33) |
| Chronic obstructive lung disease | 1.24 (1.18-1.30) |
| Peptic ulcer with bleeding or perforation | 1.17 (1.11-1.23) |
| Chronic pancreatitis | 1.09 (1.03-1.16) |
| Chronic inflammatory bowel disease | 1.08 (0.95-1.22) |
| Peptic ulcer without complications | 1.03 (0.97-1.10) |
| Acute pancreatitis | 1.01 (0.92-1.12) |
| Chronic kidney disease | 1.59 (1.37-1.83) |
| Psoriasis | 1.05 (0.92-1.21) |
| Connective tissue disease | 0.99 (0.91-1.08) |
| Epilepsy | 1.22 (1.11-1.35) |
| Schizophrenia | 1.15 (1.00-1.32) |
| Bipolar disorder | 0.98 (0.76-1.26) |
| Depression | 1.00 (0.91-1.09) |
| Dementia | 1.04 (0.95-1.15) |
| Substance abuse other than alcoholism | 1.25 (1.14-1.37) |
| Metastatic cancer | 1.72 (1.53-1.94) |
| Non-metastatic solid cancer | 1.35 (1.27-1.43) |
| Hematologic cancer | 1.30 (1.10-1.53) |
| Human immunodeficiency virus infection | 0.79 (0.49-1.26) |
| Osteoporosis | 1.03 (0.93-1.15) |
| Obesity | 1.02 (0.92-1.12) |
- Citation: Jepsen P. Comorbidity in cirrhosis. World J Gastroenterol 2014; 20(23): 7223-7230
- URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7223.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i23.7223
